Gyno-Tardyferon

Gyno‑Tardyferon is an oral vitamin and mineral supplement that combines folic acid and dried ferrous sulfate. Marketed in the European Union as an over‑the‑counter product, it helps prevent iron‑deficiency and folate‑deficiency anemia, especially in women of childbearing age. Each tablet provides a measured dose of elemental iron and folic acid to support red blood cell formation and fetal development throughout the first trimester.

Gyno‑Tardyferon is indicated for the prophylaxis and management of specific anemic conditions related to iron and folate deficiency.

- Prevention of iron‑deficiency anemia in menstruating women. - Treatment of mild to moderate folate deficiency. - Support of maternal iron and folate status during early pregnancy. - Adjunct to dietary measures in individuals with increased nutritional needs, such as athletes or those on restrictive diets. - Prevention of anemia in patients undergoing chronic blood loss, e.g., after minor surgery. - Supplementation for women with a history of recurrent pregnancy loss associated with low folate levels.

The safety profile of Gyno‑Tardyferon reflects the typical reactions observed with oral iron and folic acid preparations.

Common: - Mild gastrointestinal discomfort such as nausea or abdominal cramping. - Transient darkening of stools due to iron content. - Occasional headache or dizziness. - Slight metallic taste in the mouth. - Loose stools or mild diarrhea. - Increased frequency of urination (occasionally).

Serious: - Allergic reactions including rash, itching, or swelling of the face and throat. - Severe constipation or intestinal obstruction requiring medical attention. - Iron overload in patients with hereditary hemochromatosis may occur and require monitoring. - Worsening of folate deficiency symptoms such as megaloblastic anemia if dosing is excessive.

When using Gyno‑Tardyferon, certain precautions should be observed to minimize risks and ensure optimal benefit.

- Assess iron status before initiating therapy to avoid unnecessary supplementation. - Use with caution in individuals with known hypersensitivity to ferrous sulfate or folic acid. - Avoid use in patients with hereditary hemochromatosis or other iron‑overload disorders. - Monitor folate levels in patients with malabsorption syndromes or on anticonvulsant therapy. - Pregnant or breastfeeding women should consult a healthcare professional before starting supplementation. - Keep out of reach of children; accidental ingestion of large amounts can be harmful. - Do not exceed the recommended daily dose without medical advice.

Gyno‑Tardyferon may interact with certain medicines, affecting absorption or therapeutic effect.

Avoid: - Concurrent use with tetracycline antibiotics, which can chelate iron and reduce antibiotic efficacy. - Simultaneous intake of levothyroxine, as iron may impair thyroid hormone absorption. - Co‑administration with quinolone antibiotics (e.g., ciprofloxacin) that bind iron and lower antibiotic levels.

Use with caution: - Antacids or proton‑pump inhibitors, which may decrease iron absorption; spacing doses by at least two hours is advised. - Methotrexate therapy, where folic acid supplementation can mask toxicity; monitor closely. - Vitamin C supplements, which enhance iron absorption and may increase gastrointestinal side effects.